Ali Alkan1,2, Zeynep Gulsum Guc3, Filiz Cay Senler4, Tugba Yavuzsen3, Handan Onur4, Mutlu Dogan5, Ebru Karci4, Arzu Yasar4, Elif Berna Koksoy4, Ozgur Tanriverdi6, Serdar Turhal7, Yuksel Urun4, Asiye Ozkan4, Dilsa Mizrak4, Hakan Akbulut4. 1. Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. alkanali@yahoo.com. 2. Medical Oncology, Ankara University School of Medicine, Ankara Üniversitesi Tıp fakültesi hastanesi, Cebeci hastanesi, Tıbbi onkoloji bilim dalı, Mamak/Ankara, TR 06890, Turkey. alkanali@yahoo.com. 3. Department of Medical Oncology, Dokuz Eylül University School of Medicine, İzmir, Turkey. 4. Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. 5. Department of Medical Oncology, Numune Training and Research Hospital, Ankara, Turkey. 6. Department of Medical Oncology, Mugla Sitki Kocman University, Muğla, Turkey. 7. Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey.
Abstract
PURPOSE: Persistent postmastectomy pain syndrome (PMPS) is one of the most important disturbing symptoms. Posttraumatic stress disorder (PTSD) is an anxiety disorder which is characterized by reactions to reminders of the trauma that has been experienced. The purpose of this study is to evaluate the predictors of PMPS and PTSD in Turkish breast cancer survivors and the correlation between PMPS and PTSD. METHOD: The study is designed as a multicenter survey study. Breast cancer patients in remission were evaluated. Patients were evaluated with structured questionnaires to assess the PMPS and clinical parameters associated with it. The Turkish version of the posttraumatic stress disorder checklist-civilian version (PCL-C) was used. RESULTS: Between February 2015 and October 2015, 614 breast cancer survivors in outpatient clinics were evaluated. The incidence of PMPS documented is 45.1 %. In the multivariate analysis low income, presence of PTSD and <46 months after surgery were associated with increased risk of PMPS. PTSD was documented in 75 %, and the mean PCL-C score was 32.4 ± 11.1. PMPS and being married at the time of the evaluation were linked with PTSD. CONCLUSIONS: It is the first data about the association between PMPS and PTSD. The clinicians should be aware of PMPS and PTSD in breast cancer survivors.
PURPOSE: Persistent postmastectomy pain syndrome (PMPS) is one of the most important disturbing symptoms. Posttraumatic stress disorder (PTSD) is an anxiety disorder which is characterized by reactions to reminders of the trauma that has been experienced. The purpose of this study is to evaluate the predictors of PMPS and PTSD in Turkish breast cancer survivors and the correlation between PMPS and PTSD. METHOD: The study is designed as a multicenter survey study. Breast cancerpatients in remission were evaluated. Patients were evaluated with structured questionnaires to assess the PMPS and clinical parameters associated with it. The Turkish version of the posttraumatic stress disorder checklist-civilian version (PCL-C) was used. RESULTS: Between February 2015 and October 2015, 614 breast cancer survivors in outpatient clinics were evaluated. The incidence of PMPS documented is 45.1 %. In the multivariate analysis low income, presence of PTSD and <46 months after surgery were associated with increased risk of PMPS. PTSD was documented in 75 %, and the mean PCL-C score was 32.4 ± 11.1. PMPS and being married at the time of the evaluation were linked with PTSD. CONCLUSIONS: It is the first data about the association between PMPS and PTSD. The clinicians should be aware of PMPS and PTSD in breast cancer survivors.
Entities:
Keywords:
Breast cancer survivor; Persistent postmastectomy pain syndrome; Posttraumatic stress disorder
Authors: J S Carpenter; M A Andrykowski; P Sloan; L Cunningham; M J Cordova; J L Studts; P C McGrath; D Sloan; D E Kenady Journal: J Clin Epidemiol Date: 1998-12 Impact factor: 6.437
Authors: Orazio Caffo; Maurizio Amichetti; Antonella Ferro; Antonio Lucenti; Francesco Valduga; Enzo Galligioni Journal: Breast Cancer Res Treat Date: 2003-07 Impact factor: 4.872
Authors: Laurence Leysen; David Beckwée; Jo Nijs; Roselien Pas; Thomas Bilterys; Sofie Vermeir; Nele Adriaenssens Journal: Support Care Cancer Date: 2017-08-10 Impact factor: 3.603
Authors: Elisabeth Reiser; Anna Lena Zippl; Kilian Vomstein; Elena Strassgschwandter; Susanne Hofer-Tollinger; Germar Michael Pinggera; Bettina Toth Journal: Support Care Cancer Date: 2022-03-09 Impact factor: 3.359